Programme
28th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE
The full programme can be downloaded in pdf by clicking here
Friday, April 8th, 2022
07.45 – 08.45: |
Breakfast |
Session III. LIPOPROTEINS AND LIPID TRANSPORT |
|
08.45 – 09.10: |
Cardiac lipids and their role for cardiomyocyte function
|
09.10 – 09.15: |
Discussion |
09.15 – 09.30: |
Fibroblast growth factor 21 potently reduces atherosclerosis and NASH development |
09.30 – 09.45: |
Elevated remnant cholesterol and 2-fold mortality rates from cardiovascular and other causes, but not from cancer |
09.45 – 10.00: |
Linking cellular lipid metabolism profiles to the outcomes of cholesterol-lowering therapy in a general population cohort study |
10.00 – 10.15: |
Mapping the low-density lipoprotein interactome in mouse atherosclerosis |
10.15 – 11.15: |
Poster Walk (Session III). Coffee in dining room. |
11.15 – 11.40: |
Perilipins and regulation of intracellular lipid droplets |
11.40 – 11.45: |
Discussion |
11.45 – 12.00: |
Lipoprotein lipase expressed by vascular endothelial cells of activated thermogenic adipose tissues is dispensable for the processing of triglyceride-rich lipoproteins
|
12.00 – 12.15 |
The role of hepatic melanocortin 1 receptor in the pathogenesis and therapeutics of metabolic disease
|
12.15 – 12.30 |
Impact of preeclampsia on umbilical cord blood lipid concentrations
|
12.30 – 12.45 |
Functional analysis of LDLR variants using automated systems |
12.45 – 13.45 |
Lunch |
Session IV. CARDIOVASCULAR DISEASE |
|
13.45 – 14.10: |
Cardiovascular disease prevention: from traditional risk scores to individualized prevention
|
14.10 – 14.15: |
Discussion |
14.15 – 14.30 |
Characterization of laminin isoforms in human atherosclerotic lesions and human vascular cells
|
14.30 – 14.45 |
Pharmacological treatment with designer cytokine and exercise mimetic IC7Fc reduces atherosclerosis development
|
14.45 – 15.00 |
Inhibition of pyruvate dehydrogenase kinase prevents abdominal aortic aneurysm formation in mice
|
15.00 – 15.15: |
Endothelial integrity in intracranial atherosclerosis; the regulatory role of N6-methyladenosine (m6A) of the pro-atherogenic microRNA miR-494-3p in tight junction proteins
|
15.15 – 16.00: |
Poster Walk (Session IV). Coffee in dining room. |
16.00 – 16.25: |
Metabolic control of macrophages in atherosclerosis
|
16.25 – 16.30: |
Discussion |
16.30 – 16.45: |
Genetic deficiency of indoleamine 2,3-dioxygenase (IDO)-1 aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model
|
16.45 – 17.00: |
Atherosclerotic Plaque Progression is Associated with Increased Collagen Carbamylation: Impact on Macrophage Functioning
|
17.00 – 17.15 |
Proteomic Characterization of Atherosclerotic Lesions In Situ Using Percutaneous Coronary Intervention Angioplasty Balloons |
17.15 – 17.20 |
Concluding remarks |
17.20 – 18.30: |
Leisure time |
18.30 – 19.00: |
Cocktail |
19.00 – |
Banquet and dancing |